美国田纳西州发生一起执行失败事件。死刑犯克里斯塔·派克在周三接受致命注射后幸存下来，目前处于无意识状态并依靠呼吸机维持生命，现住在纳什维尔医院的重症监护室13。根据法庭文件，派克在执行过程中失去意识、受伤并被插管4。派克的律师称她在执行过程中"能听到哭泣、呜咽和大声呼吸的声音"3。
派克因1995年与前男友塔达里尔·希普一起参与殴打、虐待和杀害19岁受害者科琳·斯莱默而于1996年被判死刑3。派克的律师曾警告，由于她患有血小板增多症（一种血液凝结疾病）和血管细小，致命注射可能导致"不必要的"痛苦3。美国最高法院拒绝了派克律师提出的两项独立停止致命注射的申请3。派克是该州死囚牢房中唯一的女性3。
这次执行失败引发了广泛后果。州长比尔·李宣布监狱长弗兰克·斯特拉达已辞职3。李州长表示："专员斯特拉达一直以诚正的态度服务，我感谢他在这个困难时刻愿意把田纳西州人民的利益放在首位"3。州长已下令进行独立调查并暂停该州2024年的所有死刑执行3。此事件引发对致命注射是否为更人道处死方式的广泛质疑24。
Christa Pike survived a lethal injection execution in Tennessee on Wednesday, remaining alive but unconscious and dependent on mechanical ventilation in a Nashville hospital intensive care unit.3 Pike received two doses of pentobarbital during the failed procedure.3 According to court documents, Pike became unconscious, suffered burns, and required intubation.4
Pike was sentenced to death in 1996 for her role in the 1995 murder of 19-year-old Colleen Slemmer, which she committed alongside her then-boyfriend Tadaryl Shipp.3 Her legal team had previously warned that Pike's medical conditions—including thrombocythemia, a blood clotting disorder, and small blood vessels—could cause "unnecessary" suffering during lethal injection.3 During the execution, Pike's attorney reported hearing "crying, whimpering, and loud breathing sounds."3 The United States Supreme Court rejected two separate petitions from Pike's lawyers seeking to halt the lethal injection.3
Following the execution failure, Tennessee's Department of Correction Commissioner Frank Stradley resigned.3 Governor Bill Lee announced the resignation, stating that "Commissioner Stradley has served with integrity, and I'm grateful for his willingness to put the people of Tennessee first during this difficult time."3 Lee also ordered an independent investigation into the execution and suspended all capital executions scheduled in Tennessee for 2024.3 Pike's legal team is seeking sentence commutation, though the state government previously rejected her clemency request.3 Pike is the only female inmate on Tennessee's death row.3
评论
还没有评论，欢迎留下第一条。